Alterity Therapeutics Limited (NASDAQ:ATHE – Get Free Report) was up 17.5% during trading on Wednesday . The company traded as high as $2.20 and last traded at $1.88. Approximately 343,204 shares changed hands during trading, an increase of 602% from the average daily volume of 48,873 shares. The stock had previously closed at $1.60.
Alterity Therapeutics Stock Up 10.8 %
The stock has a 50 day moving average of $1.25 and a two-hundred day moving average of $1.49.
Alterity Therapeutics Company Profile
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia. The company’s lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson’s disease.
Featured Stories
- Five stocks we like better than Alterity Therapeutics
- ETF Screener: Uses and Step-by-Step Guide
- Trinity Capital CEO on Leading Private Credit’s High-Yield Growth
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Lululemon Surges On Q3 Report: Analysts Step in To Support Market
- Technology Stocks Explained: Here’s What to Know About Tech
- 10 Safe Investments with High Returns
Receive News & Ratings for Alterity Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alterity Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
